SCID Event Should Be Included In All Retroviral Therapy Informed Consent
Executive Summary
All retroviral gene therapy trial informed consent forms should include information about a leukemia-like event that occurred in a recent severe combined immunodeficiency gene therapy trial, FDA's Biological Response Modifiers Advisory Committee recommended Oct. 10